|

Trastuzumab SC Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Herceptin Hylecta

Pipeline

Phase 2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • HER2-positive Breast Cancer1
  • Breast Cancer1
  • Cancer1

San Francisco, California1 trial

ATEMPT 2.0: Adjuvant T-DM1 vs TH

UCSF Helen Diller Family Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.